Compound index

Tissue Repair & Cytoprotective Research Peptides

BPC-157

Early human trialsInvestigational

Last reviewed: 2026-11-19

Overview

A laboratory-made 15-amino-acid peptide investigated mainly in experimental injury models.

Regulatory status

No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.

    Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

    WADA prohibited status: current list and context

    Evidence at a glance

    Animal experiments and small uncontrolled human reports cannot establish structural healing or long-term safety.

    Key sources

    Identity and editorial screen completed November 19, 2026. Previously checked primary references retained; this is not an exhaustive clinical review.

    Related compounds

    • Thymosin beta-4

      Same scientific class · A 43-amino-acid chain. · Late-stage human trials

    • Thymosin beta-4 fragment (17–23)

      Same scientific class · A seven-amino-acid sequence, LKKTETQ, corresponding to residues 17–23 of thymosin beta-4. · Cell/lab studies only

    Related glossary terms